JP2022540396A5 - - Google Patents
Info
- Publication number
- JP2022540396A5 JP2022540396A5 JP2022500119A JP2022500119A JP2022540396A5 JP 2022540396 A5 JP2022540396 A5 JP 2022540396A5 JP 2022500119 A JP2022500119 A JP 2022500119A JP 2022500119 A JP2022500119 A JP 2022500119A JP 2022540396 A5 JP2022540396 A5 JP 2022540396A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025076885A JP2025124655A (ja) | 2019-07-05 | 2025-05-02 | 新規な癌抗原及び方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19184680.7 | 2019-07-05 | ||
| EP19184680 | 2019-07-05 | ||
| EP20170224 | 2020-04-17 | ||
| EP20170224.8 | 2020-04-17 | ||
| PCT/GB2020/051592 WO2021005338A2 (en) | 2019-07-05 | 2020-07-03 | Novel cancer antigens and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025076885A Division JP2025124655A (ja) | 2019-07-05 | 2025-05-02 | 新規な癌抗原及び方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022540396A JP2022540396A (ja) | 2022-09-15 |
| JP2022540396A5 true JP2022540396A5 (https=) | 2023-07-11 |
| JPWO2021005338A5 JPWO2021005338A5 (https=) | 2023-07-11 |
| JP7751817B2 JP7751817B2 (ja) | 2025-10-09 |
Family
ID=71523190
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500119A Active JP7751817B2 (ja) | 2019-07-05 | 2020-07-03 | 新規な癌抗原及び方法 |
| JP2025076885A Pending JP2025124655A (ja) | 2019-07-05 | 2025-05-02 | 新規な癌抗原及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025076885A Pending JP2025124655A (ja) | 2019-07-05 | 2025-05-02 | 新規な癌抗原及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220213159A1 (https=) |
| EP (1) | EP3993826B1 (https=) |
| JP (2) | JP7751817B2 (https=) |
| KR (1) | KR20220034040A (https=) |
| CN (1) | CN114206913A (https=) |
| AU (1) | AU2020309202A1 (https=) |
| BR (1) | BR112022000020A2 (https=) |
| CA (1) | CA3142329A1 (https=) |
| IL (1) | IL289335A (https=) |
| MX (1) | MX2022000263A (https=) |
| WO (1) | WO2021005338A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021006941A2 (pt) | 2018-10-19 | 2021-08-31 | The Francis Crick Institute Limited | Antígenos de câncer inovadores e métodos |
| CN116057067A (zh) * | 2020-04-17 | 2023-05-02 | 弗朗西斯·克里克研究所有限公司 | 用于治疗黑素瘤的ctl抗原的融合蛋白 |
| JP2023522193A (ja) * | 2020-04-17 | 2023-05-29 | ザ フランシス クリック インスティチュート リミティッド | 抗原プール |
| WO2025202937A1 (en) | 2024-03-26 | 2025-10-02 | BioNTech SE | Cancer vaccines |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002515734A (ja) | 1996-01-02 | 2002-05-28 | カイロン コーポレイション | 遺伝子改変された樹状細胞により媒介される免疫刺激 |
| US6770456B1 (en) | 1998-07-29 | 2004-08-03 | Ludwig Institute For Cancer Research | Endogenous retrovirus tumor associated nucleic acids and antigens |
| EP1586330A1 (en) | 2004-04-16 | 2005-10-19 | Georg-August-Universität Göttingen | Vaccination against malignant melanoma |
| DK1871391T3 (da) | 2005-03-30 | 2012-04-16 | Viroxis | Endogen retrovirus og proteiner, der kodes af env som target for cancerbehandling |
| WO2006105642A1 (en) * | 2005-04-05 | 2006-10-12 | British Columbia Cancer Agency | Biomarkers for the detection of lung cancer and uses thereof |
| AT502292B1 (de) * | 2005-05-11 | 2010-04-15 | Avir Green Hills Biotechnology | Melanomdiagnose |
| US8921050B2 (en) | 2006-03-17 | 2014-12-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of diagnosing renal cell carcinoma |
| US20080019979A1 (en) | 2006-05-22 | 2008-01-24 | Feng Wang-Johanning | HERV-K Antigens, Antibodies, and Methods |
| US8541553B2 (en) * | 2007-05-24 | 2013-09-24 | Baxter Healthcare Sa | Antibodies specific for the melanoma-associated endogenous retrovirus (MERV) envelope glycoprotein |
| TW201326481A (zh) * | 2011-08-30 | 2013-07-01 | Nat Defense Medical Ct | 預測易罹患卵巢贅瘤或卵巢癌預後之生物標記 |
| AU2018394238A1 (en) * | 2017-12-28 | 2020-06-18 | Lonza Sales Ag | Exosomes for immuno-oncology and anti-inflammatory therapy |
| CN116057067A (zh) * | 2020-04-17 | 2023-05-02 | 弗朗西斯·克里克研究所有限公司 | 用于治疗黑素瘤的ctl抗原的融合蛋白 |
-
2020
- 2020-07-03 WO PCT/GB2020/051592 patent/WO2021005338A2/en not_active Ceased
- 2020-07-03 MX MX2022000263A patent/MX2022000263A/es unknown
- 2020-07-03 KR KR1020217040819A patent/KR20220034040A/ko not_active Ceased
- 2020-07-03 CN CN202080049314.4A patent/CN114206913A/zh active Pending
- 2020-07-03 JP JP2022500119A patent/JP7751817B2/ja active Active
- 2020-07-03 CA CA3142329A patent/CA3142329A1/en active Pending
- 2020-07-03 EP EP20737269.9A patent/EP3993826B1/en active Active
- 2020-07-03 AU AU2020309202A patent/AU2020309202A1/en not_active Abandoned
- 2020-07-03 BR BR112022000020A patent/BR112022000020A2/pt not_active IP Right Cessation
-
2021
- 2021-12-17 US US17/644,938 patent/US20220213159A1/en active Pending
- 2021-12-23 IL IL289335A patent/IL289335A/en unknown
-
2025
- 2025-05-02 JP JP2025076885A patent/JP2025124655A/ja active Pending